Assignee
GLYCOMIMETICS INC
US·33 granted patents·44 pending applications·369 citations·filing 2002–2023
Top patents by PatentIndex Score
77 records- 0197US8039442B2Compounds and methods for treatment of sickle cell disease or complications associated therewithGLYCOMIMETICS INC·Filed 2008·Granted Oct 18, 2011·23 cites·5 claims
- 0296US8361975B2Compounds and methods for treatment of sickle cell or complications associated therewithGLYCOMIMETICS INC·Filed 2011·Granted Jan 29, 2013·20 cites·6 claims
- 0395US9109002B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2012·Granted Aug 18, 2015·32 cites·15 claims
- 0495US7989601B2Heterobifunctional pan-selectin inhibitorsGLYCOMIMETICS INC·Filed 2010·Granted Aug 2, 2011·28 cites·15 claims
- 0595US7728117B2Heterobifunctional pan-selectin inhibitorsGLYCOMIMETICS INC·Filed 2006·Granted Jun 1, 2010·29 cites·1 claims
- 0694US9867841B2Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cellsGLYCOMIMETICS INC·Filed 2013·Granted Jan 16, 2018·13 cites·13 claims
- 0794US7741312B2Compounds and methods for inhibiting selectin-mediated functionGLYCOMIMETICS INC·Filed 2006·Granted Jun 22, 2010·29 cites·4 claims
- 0894US7517980B2Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from PseudomonasGLYCOMIMETICS INC·Filed 2006·Granted Apr 14, 2009·21 cites·2 claims
- 0993US9796745B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2015·Granted Oct 24, 2017·12 cites·8 claims
- 1092US8026222B2Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosaminesGLYCOMIMETICS INC·Filed 2008·Granted Sep 27, 2011·19 cites·12 claims
- 1192US7060685B2Compounds and methods for inhibiting selectin-mediated functionGLYCOMIMETICS INC·Filed 2003·Granted Jun 13, 2006·44 cites·9 claims
- 1291US11332491B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2020·Granted May 17, 2022·2 cites·14 claims
- 1391US10766916B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2019·Granted Sep 8, 2020·3 cites·16 claims
- 1491US9534009B2Pan-selectin inhibitor with enhanced pharmacokinetic activityGLYCOMIMETICS INC·Filed 2014·Granted Jan 3, 2017·16 cites·7 claims
- 1588US10526361B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2017·Granted Jan 7, 2020·5 cites·18 claims
- 1687US11780873B2Highly potent multimeric e-selectin antagonistsGLYCOMIMETICS INC·Filed 2021·Granted Oct 10, 2023·1 cites·42 claims
- 1787US7964569B2Glycomimetic replacements for hexoses and N-acetyl hexosaminesGLYCOMIMETICS INC·Filed 2007·Granted Jun 21, 2011·19 cites·13 claims
- 1887US7361644B2Specific antagonist for both E- and P-selectinsGLYCOMIMETICS INC·Filed 2004·Granted Apr 22, 2008·25 cites·5 claims
- 1986US11072625B2Highly potent multimeric e-selectin antagonistsGLYCOMIMETICS INC·Filed 2017·Granted Jul 27, 2021·4 cites·35 claims
- 2085US11707474B2Methods for treating acute myeloid leukemia and related conditionsGLYCOMIMETICS INC·Filed 2019·Granted Jul 25, 2023·3 cites·57 claims
- 2182US11987598B2E-selectin antagonist compounds, compositions, and methods of useGLYCOMIMETICS INC·Filed 2022·Granted May 21, 2024·0 cites·65 claims
- 2282US11712446B2Methods of mobilizing marrow infiltrating lymphocytes and uses thereofGLYCOMIMETICS INC·Filed 2018·Granted Aug 1, 2023·1 cites·14 claims
- 2382US10519181B2Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptorsGLYCOMIMETICS INC·Filed 2015·Granted Dec 31, 2019·4 cites·31 claims
- 2479US11197877B2Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonistsGLYCOMIMETICS INC·Filed 2018·Granted Dec 14, 2021·2 cites·53 claims
- 2579US7135301B2Detection and treatment of prostate cancerGLYCOMIMETICS INC·Filed 2002·Granted Nov 14, 2006·12 cites·2 claims
- 2678US2024165139A1Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonistsGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 2776US2023365609A1Highly potent multimeric e-selectin antagonistsGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 2874US11845771B2Heterobifunctional inhibitors of E-selectin and galectin-3GLYCOMIMETICS INC·Filed 2019·Granted Dec 19, 2023·1 cites·61 claims
- 2973US11878026B2Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonistsGLYCOMIMETICS INC·Filed 2021·Granted Jan 23, 2024·0 cites·29 claims
- 3072US2023414642A1Methods of mobilizing marrow infiltrating lymphocytes and uses thereofGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 3172US2024150388A1Heterobifunctional inhibitors of e-selectin and galectin-3GLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 3269US2023127765A1Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4GLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 3368US7727735B2Detection and treatment of prostate cancerGLYCOMIMETICS INC·Filed 2006·Granted Jun 1, 2010·1 cites·1 claims
- 3468US2023414641A1Methods for treating acute myeloid leukemia and related conditionsGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 3563US2014178303A1Heterobifunctional pan-selectin inhibitorsGLYCOMIMETICS INC·Filed 2013·Application pending·0 cites
- 3660US11433086B2Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4GLYCOMIMETICS INC·Filed 2017·Granted Sep 6, 2022·0 cites·12 claims
- 3760US2016289257A1Glycomimetic compounds and methods to inhibit infection by hivGLYCOMIMETICS INC·Filed 2016·Application pending·0 cites
- 3859US2024269157A1Compositions and methods for overcoming microenvironment-mediated resistance via e-selectin targetingGLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 3959US2016361332A1Heterobifunctional pan-selectin inhibitorsGLYCOMIMETICS INC·Filed 2016·Application pending·0 cites
- 4058US2009176717A1Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonasGLYCOMIMETICS INC·Filed 2007·Application pending·0 cites
- 4157US2023364277A1E-selectin targeting agentsGLYCOMIMETICS INC·Filed 2021·Application pending·0 cites
- 4257US2024417420A1Polar cd33 ligands suitable for incorporation into carriersGLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 4357US2014073594A1Glycomimetic compounds and methods to inhibit infection by hivGLYCOMIMETICS INC·Filed 2013·Application pending·0 cites
- 4455US2004219158A1Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteriaGLYCOMIMETICS INC·Filed 2003·Application pending·0 cites
- 4555US2024270724A1Galectin-3 inhibiting c-glycosidesGLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 4655US2024287121A1Galectin-3 inhibiting c-glycoside oximesGLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 4753US2023167150A1Cd33 ligands suitable for incorporation into carriersGLYCOMIMETICS INC·Filed 2021·Application pending·0 cites
- 4853US2023218649A1Compositions and methods for overcoming microenvironment-mediated resistance via e-selectin targetingGLYCOMIMETICS INC·Filed 2021·Application pending·0 cites
- 4953US2023167149A1Cd33 ligands suitable for incorporation into carriersGLYCOMIMETICS INC·Filed 2021·Application pending·0 cites
- 5053US2004096396A1Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesisGLYCOMIMETICS INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GLYCOMIMETICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →